サインイン

Skeletal muscle relaxants can target the central nervous system [CNS]to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.

Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs, such as baclofen, diazepam, and tizanidine, primarily act on the CNS. Most of these drugs are administered orally, although some may be given intramuscularly or intravenously. The duration of action of these drugs typically ranges from 5 to 24 hours. Spasmolytic drugs are commonly used to manage severe and chronic spasms caused by conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injuries, and muscle injuries. However, they may have side effects such as sedation, weakness, hypotension, and the potential for rebound spasticity upon discontinuing the medication. Antispasmodics have a shorter duration of action, typically lasting from 4 to 6 hours. They can produce strong antimuscarinic effects such as constipation, bradycardia, and urinary retention. An example of an antispasmodic drug is cyclobenzaprine, which is primarily given orally to treat acute spasms resulting from muscle injuries.

Peripherally acting drugs are also classified into neuromuscular blockers and directly acting agents. Succinylcholine, d-tubocurarine, cisatracurium, and rocuronium are some examples of neuromuscular blockers. These drugs are often administered intravenously. Their duration of action ranges from 5 to 60 minutes. These are given along with anesthetics to prolong muscle relaxation during surgeries. They can cause side effects like hypotension, prolonged apnea, intraocular pressure, and postoperative muscle pain. Dantrolene and botulinum toxin are examples of directly acting relaxants that are administered intramuscularly or orally. Duration of action ranges from 4 hours to 2 months. These medications weaken muscle contraction, leading to flaccid paralysis, and effectively treat spasms caused by conditions such as cerebral palsy, multiple sclerosis, and overactive bladder

タグ

Muscle RelaxantsCentrally ActingPeripherally ActingSpasmolytic DrugsAntispasmodic DrugsNeuromuscular BlockersMuscle Tension ReductionBaclofenDiazepamTizanidineCyclobenzaprineSuccinylcholineDantroleneBotulinum ToxinSide EffectsDuration Of Action

章から 7:

article

Now Playing

7.12 : Peripherally and Centrally Acting Muscle Relaxants: A Comparison

骨格筋弛緩薬

2.9K 閲覧数

article

7.1 : 神経筋接合部と遮断

骨格筋弛緩薬

2.6K 閲覧数

article

7.2 : 骨格筋弛緩薬の分類

骨格筋弛緩薬

2.3K 閲覧数

article

7.3 : 非脱分極性(競合的)神経筋遮断薬:作用機序

骨格筋弛緩薬

1.2K 閲覧数

article

7.4 : 非脱分極性(競合性)神経筋遮断薬:薬理作用

骨格筋弛緩薬

342 閲覧数

article

7.5 : 非脱分極性(競合性)神経筋遮断薬:薬物動態

骨格筋弛緩薬

404 閲覧数

article

7.6 : 脱分極ブロッカー:作用機序

骨格筋弛緩薬

1.0K 閲覧数

article

7.7 : 脱分極ブロッカー:ファーモコキネティクス

骨格筋弛緩薬

277 閲覧数

article

7.8 : 直接作用性筋弛緩薬:ダントロレンとボツリヌス毒素

骨格筋弛緩薬

596 閲覧数

article

7.9 : 骨格筋弛緩薬:副作用

骨格筋弛緩薬

306 閲覧数

article

7.10 : 骨格筋弛緩薬:治療用途

骨格筋弛緩薬

432 閲覧数

article

7.11 : 鎮痙剤:化学分類

骨格筋弛緩薬

828 閲覧数

article

7.13 : 中枢作用型筋弛緩薬:治療用途

骨格筋弛緩薬

558 閲覧数

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved